Mesalamine (generic), Asacol, Pentasa News

Dear Dr. Gott: I have a relative who is nearly 50 years old. About 30 years ago, he suffered with gastroenteritis and was on Donnatal.

Santarus, Inc. , a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA , has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX administered over eight weeks for the induction of remission of mild ...

Frederick resident Keith Krause said he is finding some good results with Remicade in his fight against ulcerative colitis which carries with it symptoms such as constant diarrhea, weight loss and a lack of energy.

I was diagnosed with Crohn's disease in February 2007 and was initially prescribed the Entocort/Pentasa regimen which was not tolerable.

I am taking Asacol I've noticed the meds full in my stool. Has this happened to anyone? This started over a year ago while I was about 6 months pregnant.

" Results from the largest prospective controlled ulcerative colitis trial conducted to date, called the QD dosing investigation for efficacy IN UC maintenance , found that once-daily dosing of AsacolA delayed-release 400 mg tablets at 1.6-2.4 g/day was comparable to twice-daily dosing for the maintenance of remission in patients with UC.

Shire plc , the global specialty biopharmaceutical company, presented the results of three 5-aminosalicylic acid persistency analyses at ACG 2009 Annual Scientific Meeting, evaluating persistency of Lialda , Asacol , Pentasa , balsalazide [combined results from generic balsalazide disodium and Colazal ], and Dipentum .

Shares of Warner Chilcott PLC rallied Monday as investors greeted the Irish-based drugmaker's agreement to buy Procter & Gamble Co.'s branded pharmaceuticals unit for $3.1 billion in cash.

Sells unit to Warner Chilcott for an up-front cash payment of $3.1 billion. Procter & Gamble has sold its pharmaceutical unit to Warner Chilcott, a specialty pharmaceutical company based in Ireland,for $3.1 billion.

Drug stocks were nominally higher Monday, while shares of Ireland-based Warner Chilcott PLC rallied after the company announced it would buy Procter & Gamble Co.'s branded pharmaceuticals unit for $3.1 billion in cash.

Procter & Gamble Co. has finalized a deal to sell its pharmaceutical business to Warner Chilcott Plc , a step in its plan to unload what it considers less profitable and non-core businesses.

REPORT OF A CASE A 22-year-old woman visited our clinic after developing a skin eruption over several days.

Mesalazine is an effective and safe approach to reduce mast cell infiltration and improve general well-being in patients with IBS, find researchers in the August issue of Alimentary Pharmacology and Therapeutics .

For patients with quiescent ulcerative colitis, a single 2-gram dose of mesalamine daily is better than two 1-gram doses daily, according to a study in the July issue of Clinical Gastroenterology and Hepatology .

UC involves inflammation of the lining of the colon and rectum and is typically characterized by flares followed by periods of remission.

Biological drugs are the big winners in the market for autoimmune disorders. According to "Autoimmune Market Forecast to 2014," the latest therapeutic market forecast from Cutting Edge Information, 11 of 14 drugs projected to reach blockbuster status are biologics.

Lately, my Twitter friends have alerted me to all sorts of examples of pharmaceutical companies delving into social media for marketing and corporate communications.

Let's face it... nobody enjoys having IBD. It hit me like a brick wall. I found I had to plan my whole day around where the closest bathroom was.

Study uses SmartPill capsule in ulcerative colitis patients, finding acidic conditions in their colons An electronic diagnostic tool called the SmartPill is swallowed by patients in order to take measurements as it travels through the gastrointestinal tract.

Data was announced today that demonstrated Salix Pharmaceuticals' APRISO 0.375g extended-release capsules had a favorable safety profile in patients in remission from ulcerative colitis for up to 24 months.